A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma
Titel:
A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma
Auteur:
Varker, Kimberly A. Biber, Jennifer E. Kefauver, Cheryl Jensen, Rhonda Lehman, Amy Young, Donn Wu, Haifeng Lesinski, Gregory B. Kendra, Kari Chen, Helen X. Walker, Michael J. Carson III, William E.